What Is The Best Substitute For Xarelto?
Eliquis is considered to the answer for question “What is the best substite for Xarelto”. The article below will show comparison of these medicines.
Prior to these medications, patients depended mostly on warfarin, which was launched 64 years ago. Warfarin is still the most often prescribed anticoagulant today, although NOACs in general are rapidly gaining momentum. With multiple warfarin alternatives to select from, patients and their doctors may now weigh aspects such as cost, side effects, and inconvenience to choose which one is best for them.
What are the prices of these anticoagulants?
Because NOACs are still relatively new, they are only available as pricey brand-name medications. For a monthly supply of Eliquis or Xarelto, the typical retail price is roughly $550. Warfarin, a generic, costs only $19 out of pocket.
| Drug name | Average retail price | Lowest GoodRx price |
|---|---|---|
| Warfarin | $18.59 | $3.00 |
| Eliquis | $556.15 | $458.07 |
| Xarelto | $553.65 | $461.93 |
Shall a generic version of Eliquis or Xarelto be available soon?
Eliquis and Xarelto have patents that expire in 2023 and 2021, respectively. Competitors will only be able to create and sell generic equivalents after that.
Is the cost of Eliquis and Xarelto justified?
Warfarin therapy needs regular blood tests to ensure that the dosage is accurate. Besides, how much of the medication is required depends on food, activity, and alcohol use. These are not factors to consider when using NOACs, and most patients regard this as a benefit. It is most likely the primary reason why many people are willing to discontinue warfarin.
We looked at poll results collected by our partner website, Iodine.com, to examine how Eliquis and Xarelto compare in terms of value and efficacy to warfarin. Iodine informs you about what to anticipate from drugs by integrating real-world experience from thousands of patients with expert advice from pharmacists and the FDA.
| Drug name | Worth it | Worked well | Big hassle |
|---|---|---|---|
| Warfarin | 61% | 54% | 21% |
| Eliquis | 47% | 58% | 21% |
| Xarelto | 45% | 45% | 9% |
Though 21% of persons who have used warfarin believed it was a major nuisance, more than half said the medication’s advantages outweighed the drawbacks. Xarelto and Eliquis have comparable worth it rankings, however Xarelto appears to be less of a problem. Even while all three therapies scored similarly in terms of how successful individuals felt they were, just half of the participants thought anticoagulants performed well in general.
It’s important to note that all anticoagulants involve the potential of bleeding-related adverse effects such nosebleeds, bruises, blue or purple toes, and even internal bleeding (with signs like dark urine or bloody stools). People who take Eliquis or Xarelto are also more prone to have nausea or stomach distress.
